跳至主要内容
临床试验/NCT06034340
NCT06034340已完成不适用

Rapid Local Anesthesia by Lidocaine Administered Using STAR Particles

Emory University2 个研究点 分布在 1 个国家目标入组 22 人开始时间: 2023年3月19日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
22
试验地点
2
主要终点
Application Site Pain Assessment

研究概览

简要总结

This study is being done to answer the question: Do STAR particles (tiny pieces of ceramic with small spikes) help numbing gel (a gel that helps you feel less pain) work more quickly to provide local anesthesia or numbing in a specific area? Research participants will provide feedback on how quickly the STAR particles with the numbing gel can provide anesthesia. Participants will report their sensation at either 10 or 20 minutes after application of the numbing gel.

详细描述

This study aims to find out if the combination of STAR particles with numbing gel can deliver anesthesia faster than applying the gel by itself. STAR particles are very small particles with microneedles on the surface that can increase and create small punctures in the skin. The small punctures should allow for the numbing gel to work more quickly and allow the area to become numb more quickly.

After pretreatment with STAR particles (applied to the right or left arm) and aloe gel (used as a control condition in the contralateral arm) a numbing gel will be applied. A Pin-Prick test will be performed to evaluate local anesthesia from the numbing gel; half the participants will be evaluated 10 minutes after application of the numbing gel and the other half will be assessed 20 minutes after the numbing gel is applied. The study team will also assess pain after needle insertion and measure how much water is being lost from the skin using a device called a Vapometer before and after the STAR particle and aloe gel applications. Participants will have follow-up calls 24 hours and 1 week after the visit to ask about any changes to the skin where the STAR particles were applied.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
10 Years 至 21 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Children, adolescents, and young adults, 10 to 21 years of age
  • In good general health as determined by a medical history
  • Willing to provide informed assent with parental consent and follow study requirements

排除标准

  • Is chronically using pain medication
  • Has a plan to move to another location in the next 12 months or foresees any other reason that participation in the study would be disrupted during the next 12 months
  • Has skin disorders or skin allergies
  • Has any previous allergy or adverse reaction to STAR particle ingredients (Titanium Dioxide)
  • Has abnormal (e.g., tattooed) skin at proposed the site(s) of STAR particle application
  • Has known neurological conditions that might affect sensory function or perception of pain
  • Has any condition (social or medical), which in the opinion of the investigator would make study participation unsafe, would interfere with adherence to the clinical study requirements, or would complicate data interpretation

结局指标

主要结局

Application Site Pain Assessment

时间窗: Day 1 at 10 minutes or 20 minutes after application of LET gel

The application site pain assessment was measured by using the visual analog scale (VAS). The VAS consists of a 10 centimeter (cm) line with opposite endpoints representing "no pain" (coded as 0) and "pain as bad as it could possibly be" (coded as 10).

Percent of Sharp (as Opposed to Dull) Sensation Over Application Area

时间窗: Day 1 at 10 minutes or 20 minutes after application of LET gel

The time to achieve anesthesia is assessed as the percent of sharp (as opposed to dull) sensation reported at 10 or 20 minutes after the application of LET gel.

次要结局

  • Change in Transepidermal Water Loss (TEWL)(Day 1 at baseline and immediately after application of LET gel)
  • Number of Participants Experiencing Serious Adverse Events(Immediately after application, 1 hour after application and up to 1 week after application)
  • Number of Participants Experiencing Adverse Events(Immediately after application, 1 hour after application and up to 1 week after application)
  • Number of Participants With Acute Skin Reactions (ASRs)(Immediately, 1 hour, 24 hours, and 7 days after application.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Eric Felner

Professor of Pediatrics

Emory University

研究点 (2)

Loading locations...

相似试验

Lidocaine Administration Using STAR Particles | 临床试验